-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ToPPPcfrE0p1TRR3Ufy4EzV8q/O9r3G78Q/4PeOYwKXjx0e/jNu9So/3cet4ZvGv MfM+R+StL2Ne5TKyhJyKVA== 0001047469-03-001739.txt : 20030121 0001047469-03-001739.hdr.sgml : 20030120 20030117173548 ACCESSION NUMBER: 0001047469-03-001739 CONFORMED SUBMISSION TYPE: 15-12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20030121 EFFECTIVENESS DATE: 20030121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ENCHIRA BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0000895677 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043078857 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-12G SEC ACT: 1934 Act SEC FILE NUMBER: 000-21130 FILM NUMBER: 03518458 BUSINESS ADDRESS: STREET 1: 4200 RESEARACH FOREST DR CITY: THE WOODLANDS STATE: TX ZIP: 77381 BUSINESS PHONE: 2813646142 MAIL ADDRESS: STREET 1: 4200 RESEARCH FOREST DR CITY: THE WOODLANDS STATE: TX ZIP: 77381 FORMER COMPANY: FORMER CONFORMED NAME: ENERGY BIOSYSTEMS CORP DATE OF NAME CHANGE: 19940204 15-12G 1 a2101053z15-12g.htm FORM 15-12G

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 15
Certification and Notice of Termination of Registration under Section 12(g) of the Securities Exchange
Act of 1934 or Suspension of Duty to File Reports under Sections 13 and 15(d)
of the Securities Exchange Act of 1934.

Commission File Number: 0-21130

Enchira Biotechnology Corporation
(Exact name of registrant as specified in its charter)

4200 Research Forest Drive
The Woodlands, Texas 77381
(281) 419-7000
(Address, including zip code, and telephone number, including area code of
registrant's principal executive offices)

Common Stock, par value $0.01 per share
Preferred Stock Purchase Rights
(Title of each class of securities covered by this Form)

None
(Titles of all other classes of securities for which a duty to file reports
under section 13(a) or 15(d) remains)

        Please provide an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 
Rule 12g-4(a)(1)(i)
 
/x/
 
Rule 12h-3(b)(1)(i)
 
/x/
  Rule 12g-4(a)(1)(ii)   / /   Rule 12h-3(b)(1)(ii)   / /
  Rule 12g-4(a)(2)(i)   / /   Rule 12h-3(b)(2)(i)   / /
  Rule 12g-4(a)(2)(ii)   / /   Rule 12h-3(b)(2)(ii)   / /
          Rule 15d-6   / /

        Approximate number of holders of record as of the certification or notice date:    148

        Pursuant to the requirements of the Securities Exchange Act of 1934 as amended, Enchira Biotechnology Corporation has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

        Dated: January 17, 2003

    ENCHIRA BIOTECHNOLOGY CORPORATION

 
 
By:
/s/  PAUL G. BROWN, III      
Name: Paul G. Brown, III
Title: President

-----END PRIVACY-ENHANCED MESSAGE-----